@article{ref1,
title="Placebo-controlled, randomized trial of fluoxetine in the treatment of aggression in male intimate partner abusers",
journal="International clinical psychopharmacology",
year="2008",
author="Lee, Robin and Kavoussi, R. J. and Coccaro, E. F.",
volume="23",
number="6",
pages="337-341",
abstract="The objective was to determine the efficacy of treating aggressive behavior in men, with a history of intimate partner abuse, with fluoxetine. Twenty-six men with a history of intimate-partner-abusing behavior entered a randomized, placebo-controlled trial of fluoxetine (20-60 mg by mouth per day). The primary outcome measure was the Aggression score from the overt aggression scale-modified (OAS-M). Fluoxetine-treated patients (n=13) did not differ from placebo-treated patients (n=13) on any key demographic or behavioral variables. Although a significant 'pre-post' reduction in OAS-M Aggression score was noted in all patients, no drug-placebo differences for OAS-M Aggression scores were seen in any analysis. Despite the small sample, these results do not support the hypothesis that treatment with an SSRI is associated with a reduction in aggressive behavior among men with a history of intimate partner abuse.<p /> <p>Language: en</p>",
language="en",
issn="0268-1315",
doi="10.1097/YIC.0b013e32830fbdd2",
url="http://dx.doi.org/10.1097/YIC.0b013e32830fbdd2"
}